Platelets in Inflammation and Thrombosis

Inflammation and Allergy - Drug Targets

Volumn 9, Issue 5, 2010, Pages 319-321

  Gasparyan, Armen Yuri ^a  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; PRASUGREL;

BERNARD SOULIER DISEASE; CARDIOVASCULAR DISEASE; DRUG MECHANISM; EDITORIAL; GLANZMANN DISEASE; HUMAN; INFLAMMATION; MEGAKARYOCYTE; RHEUMATIC DISEASE; THROMBOCYTE; THROMBOSIS; TREATMENT RESPONSE;

ANIMALS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; THROMBOSIS;

EID: 79751511868     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (40)

1. Kaushansky, K. Historical review: megakaryopoiesis and thrombopoiesis. Blood, 2008, 111(3), 981-986.
2. Lindemann, S; Gawaz, M. The active platelet: translation and protein synthesis in an anucleate cell. Semin. Thromb. Hemost., 2007, 33(2), 144-150.
3. Kannan, M.; Ahmad, F.; Yadav, B.K.; Anand, M.; Jain, P.; Kumar, R.; Saxena, R. Glanzmann's thrombasthenia in North Indians: sub classification and carrier detection by flow cytometry. Platelets, 2009, 20(1), 12-15.
4. Toogeh, G.; Sharifian, R.; Lak, M.; Safaee, R.; Artoni, A.; Peyvandi, F. Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran. Am. J. Hematol., 2004, 77(2), 198-199.
5. Toogeh, G.; Keyhani, M.; Sharifian, R.; Safaee, R.; Emami, A.; Dalili, H. A study of Bernard-Soulier syndrome in Tehran, Iran. Arch. Iran. Med., 2010, 13(6), 549-551.
6. Beltrame, M.P.; Malvezzi, M.; Zanis, J.; Pasquini, R. Flow cytometry as a tool in the diagnosis of Bernard-Soulier syndrome in Brazilian patients. Platelets, 2009, 20(4), 229-234.
7. Surin, W.R.; Barthwal, M.K.; Dikshit, M. Platelet collagen receptors, signaling and antagonism: emerging approaches for the prevention of intravascular thrombosis. Thromb. Res., 2008, 122(6), 786-803.
8. Gasparyan, A.Y.; Watson, T.; Lip, G.Y. The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J. Am. Coll. Cardiol., 2008, 51(19), 1829-1843.
9. Garraud, O.; Cognasse, F. Platelet Toll-Like Receptor Expression: The Link between Danger Ligands and Inflammation. Inflamm. Allergy Drug Targets, 2010, 9(5), 322-333.
10. Yeaman, M.R. Platelets in defense against bacterial pathogens. Cell. Mol. Life Sci., 2010, 67(4), 525-544.
11. Blair, P.; Flaumenhaft, R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev., 2009, 23(4), 177-189.
12. Ferroni, P.; Basili, S.; Davi, G. Platelet activation, inflammatory mediators and hypercholesterolemia. Curr. Vasc. Pharmacol., 2003, 1(2), 157-169.
13. Woollard, K.J.; Chin-Dusting, J. Therapeutic targeting of p-selectin in atherosclerosis. Inflamm. Allergy Drug Targets, 2007, 6(1), 69-74.
14. Antoniades, C.; Bakogiannis C.; Tousoulis, D.; Demosthenous, M.; Marinou, K.; Stefanadis, C. Platelet Activation in Atherogenesis Associated with Low-Grade Inflammation. Inflamm. Allergy Drug Targets, 2010, 9(5), 334-345.
15. Antoniades, C.; Bakogiannis, C.; Tousoulis, D.; Antonopoulos, A.S.; Stefanadis, C. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J. Am. Coll. Cardiol., 2009, 54(8), 669-677.
16. Vasina, E.; Heemskerk, J.W.; Weber, C.; Koenen, R.R. Platelets and Platelet-Derived Microparticles in Vascular Inflammatory Disease. Inflamm. Allergy Drug Targets, 2010, 9(5), 346-354.
17. Koenen, R.R.; Weber, C. Platelet-derived chemokines in vascular remodeling and atherosclerosis. Semin. Thromb. Hemost., 2010, 36(2), 163-169.
18. Boilard, E.; Nigrovic, P.A.; Larabee, K.; Watts, G.F.; Coblyn, J.S.; Weinblatt, M.E.; Massarotti, E.M.; Remold-O'Donnell, E.; Farndale, R.W.; Ware, J.; Lee, D.M. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science, 2010, 327(5965), 580-583.
19. Gasparyan, A.Y.; Stavropoulos-Kalinoglou, A.; Mikhailidis, D.P.; Douglas, K.M.; Kitas, G.D. Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol. Int., 2010 Apr 14. DOI: 10.1007/s00296-010-1446-x. [Epub ahead of print].
20. Sentürk, T. Platelet Function In Inflammatory Diseases: Insights From Clinical Studies. Inflamm. Allergy Drug Targets, 2010, 9(5), 355-363.
21. Gasparyan, A.Y.; Stavropoulos-Kalinoglou, A.; Toms, T.E.; Douglas, K.M.; Kitas, G.D. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm. Allergy Drug Targets, 2010, 9(1), 45-50.
22. Gasparyan, A.Y.; Stavropoulos-Kalinoglou, A.; Mikhailidis, D.P.; Toms, T.E.; Douglas, K.M.; Kitas, G.D. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr. Vasc. Pharmacol., 2010, 8(4), 437-449.
23. Gasparyan, A.Y.; Sandoo, A.; Stavropoulos-Kalinoglou, A.; Kitas, G.D. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti- TNF-alpha therapy. Rheumatol. Int., 2010, 30(8), 1125-1129.
24. van der Loo, B.; Martin, J.F. Megakaryocytes and platelets in vascular disease. Baillieres Clin. Haematol., 1997, 10(1), 109-123.
25. Yetkin, E. Mean platelet volume not so far from being a routine diagnostic and prognostic measurement. Thromb. Haemost., 2008, 100(1), 3-4.
26. Muhlestein, J.B. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Thromb. Haemost., 2010, 103(1), 71-82.
27. Acikel, S.; Akdemir, R. The relationship between inflammation, platelet activation and antiplatelet resistance. Inflamm. Allergy Drug Targets, 2010, 9(5), 364-381.
28. Husted, S.; Storey, R.F.; Harrington, R.A.; Emanuelsson, H.; Cannon, C.P. Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel. Clin. Cardiol., 2010, 33(4), 206-212.
29. Gasparyan, A.Y. Aspirin and clopidogrel resistance: methodological challenges and opportunities. Vasc. Health Risk Manag., 2010, 6, 109-112.
30. Lev, E.I.; Solodky, A.; Harel, N.; Mager, A.; Brosh, D.; Assali, A.; Roller, M.; Battler, A.; Kleiman, N.S.; Kornowski, R. Treatment of aspirinresistant patients with omega-3 fatty acids versus aspirin dose escalation. J. Am. Coll. Cardiol., 2010, 55(2), 114-121.
31. Eapen, D.; Kalra, G.L.; Merchant, N.; Arora, A.; Khan, B.V. Metabolic syndrome and cardiovascular disease in South Asians. Vasc. Health Risk Manag., 2009, 5, 731-743.
32. Dodani, S. Atherothrombosis in South Asians: Implications of Atherosclerotic and Inflammatory Markers. Open Cardiovasc. Med. J., 2010, 4, 45-50.
33. Miller, M.A.; Cappuccio, F.P. Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population. Int. J. Obes. (Lond.), 2006, 30(8), 1176-1182.
34. Dotsenko, O.; Chaturvedi, N.; Thom, S.A.; Wright, A.R.; Mayet, J.; Shore, A.; Schalkwijk, C.; Hughes, A.D. Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men. J. Thromb. Haemost., 2007, 5(10), 2036-2042.
35. Dodani, S. Do We Need More Research on Platelet Function in South Asian Immigrants? Inflamm. Allergy Drug Targets, 2010, 9(5), 382-386.
36. Pournourmohammadi, S.; Khazaeli, P.; Eslamizad, S.; Tajvar, A.; Mohammadirad, A.; Abdollahi, M. Study on the oxidative stress status among cement plant workers. Hum. Exp. Toxicol., 2008, 27(6), 463-469.
37. Sithu, S.D.; Srivastava, S.; Siddiqui, M.A.; Vladykovskaya, E.; Riggs, D.W.; Conklin, D.J.; Haberzettl, P.; O'Toole, T.E.; Bhatnagar, A.; D'Souza, S.E. Exposure to acrolein by inhalation causes platelet activation. Toxicol. Appl. Pharmacol., 2010, 248(2), 100-110.
38. Poursafa, R.; Kelishadi, R. Air Pollution, Platelet Activation and Atherosclerosis. Inflamm. Allergy Drug Targets, 2010, 9(5), 387-392.
39. Jacobs, L.; Emmerechts, J.; Mathieu, C.; Hoylaerts, M.F.; Fierens, F.; Hoet, P.H.; Nemery, B.; Nawrot, T.S. Air pollution related prothrombotic changes in persons with diabetes. Environ. Health Perspect., 2010, 118(2), 191-196.
40. Salari Sharif, P.; Abdollahi, M. The Role of Platelets in Bone Remodeling. Inflamm. Allergy Drug Targets, 2010, 9(5), 393-399.